Pharmacy

Pfizer CEO Albert Bourla, PhD, laid out a timeline Oct. 16 for reaching key milestones in the drugmaker's COVID-19 vaccine development. 

The percentage of Americans who say they are likely to receive a COVID-19 vaccine as soon as one becomes available is dwindling, according to a recent survey conducted by STAT and the Harris Poll.

CVS Health is recruiting workers to fill 15,000 new positions as a part of its pandemic response, the company said Oct. 19.

Reno, Nev.-based Renown Health named Adam Porath, PharmD, its vice president of pharmacy Oct. 16.

Walgreens and CVS Health have partnered with Operation Warp Speed, the White House task force to develop a COVID-19 vaccine, to administer the vaccines to high-priority groups at long-term care facilities when one becomes available.

The FDA now requires the bottle labeling or prescribing information for nonsteroidal anti-inflammatory drugs to disclose the risks associated with their use in people who are pregnant, the agency announced Oct. 15.

HHS said it will give $31 million to Massachusetts pharmaceutical manufacturer Cytiva to scale up its production of materials needed to produce COVID-19 vaccines, the department announced Oct. 13.

Regeneron's Inmazeb gained FDA approval Oct. 14, becoming the first Ebola treatment to receive approval by the agency.

Pfizer received FDA approval to test the COVID-19 vaccine it's developing with BioNTech in children as young as 12, one of the trial's lead researchers told CNN Oct. 13.

Walgreens Boots Alliance shared its financial results for the fiscal year and fourth quarter that ended Aug. 31, reporting earnings that were higher than its expectations and predicting single-digit profit growth in 2021.